Healthineers Spins Off Diagnostics as Olyrian and Slashes €700 Million in Costs
Published on 11/15/2026 at 15:52 | Editorial boerse-global.de
Siemens Healthineers is preparing to cut its in-vitro diagnostics unit loose. The German medical-technology group has kicked off a carve-out that will see the business set up as a standalone organisation under the name Olyrian Diagnostics, with the separation targeted for completion by mid-2028. Until then, Olyrian remains part of Siemens Healthineers.
The move comes alongside fourth-quarter figures for fiscal 2026, released on 5 November, which showed comparable revenue growth of 5.9% and an adjusted EBIT margin of 15.9%.
A €700 Million Cost Offset
To absorb the expense of the break-up, Healthineers has unveiled a savings programme dubbed "Transform4 Future." From 2028, more than €300 million in costs are to be offset across the group — burdens stemming from the planned diagnostics spin-off, the separation from Siemens and a downsizing of the ultrasound business. Finance chief Jochen Schmitz added that the diagnostics division being carved out will deliver a further €400 million in savings.
Should investors sell immediately? Or is it worth buying Siemens Healthineers?
Guidance for fiscal 2027 points to comparable revenue growth of 4.0–5.0%, with adjusted unadjusted earnings per share pencilled in at €2.20–2.40.
Analysts Split on the Outlook
The quarterly update drew a mixed reception on the sell side. Analyst Graham Doyle flagged expected charges tied to the diagnostics separation, noting that group revenue growth came in slightly ahead of expectations while adjusted operating profit (EBIT) fell short.
Deutsche Bank Research raised its price target to €43 from €39 on Wednesday, keeping a "Hold" rating. Bernstein Research moved the other way on Thursday, downgrading the stock from "Outperform" to "Market-Perform" and trimming its target to €44 from €44.50. Analyst Susannah Ludwig pointed to the richer valuation, another year of limited earnings-per-share growth and little room for a re-rating. Shares nonetheless added 1.1% on Friday.
A New Name for the Parent
Healthineers and Siemens also confirmed on 5 November that, following the spin-off and deconsolidation slated for 2027, the remaining company will trade simply as "Healthineers." Shareholders must approve the change at the annual general meeting in February 2027. The brand rollout is set to begin in 2027 and run for three years.
Ad
Siemens Healthineers Stock: New Analysis - 15 November
Fresh Siemens Healthineers information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
